The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
775
September 23, 1988
View Complete Issue         Table of Contents 2019 
Metrodin and Other Drugs That Induce Ovulation
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Metrodin and Other Drugs That Induce Ovulation
September 23, 1988 (Issue: 775)
Urofollitropin (Metrodin - Serono), a human gonadotropin, is the latest drug to be approved by the US Food and Drug Administration (FDA) for induction of ovulation in various clinical situations, including in vitro fertilization (IVF).
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Metrodin and Other Drugs That Induce Ovulation
Article code: 775b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.